Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,471.00    11.00 (0.75%)
Bid:
1,475.00
Ask:
1,477.00
Spread: 2.00 (0.136%)
Market Cap: £3.13b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Option Exercise

19 Sep 2007 16:22

Hikma Pharmaceuticals Plc19 September 2007 For Immediate Release 19 September 2007 Hikma Pharmaceuticals PLC (the "Company") Director/PDMR Shareholding Notification of Option Exercise On 19 September 2007 the following PDMRs exercised their option to purchase thenumber of ordinary shares of 10 pence each set out in the table below in thecapital of the Company. These options were granted on the dates shown belowpursuant to the Company's 2004 Stock Option Plan: +--------------------+---------------+-------------------------------------+|Name |Date of Grant |Number of Shares Exercised |+--------------------+---------------+-------------------------------------+|Majda Labadi |12 October 2004|120,000 |+--------------------+---------------+-------------------------------------+|Taghreed Al Shunnar |12 October 2004|120,000 |+--------------------+---------------+-------------------------------------+ On 19 September 2007, the PDMRs disposed of the following number of shares acquired pursuant to the exercise of the options set out above: +-------------------+-----------------+------------------------+-------------------------+---------------------------+|Name |Date of Disposal |Market Price on Disposal|Number of Shares Disposed|Percentage of Share capital|| | | | | |+-------------------+-----------------+------------------------+-------------------------+---------------------------+|Majda Labadi |19 September 2007|£4.210201 |120,000 |0.0708% |+-------------------+-----------------+------------------------+-------------------------+---------------------------+|Taghreed Al Shunnar|19 September 2007|£4.210201 |120,000 |0.0708% |+-------------------+-----------------+------------------------+-------------------------+---------------------------+ As a result of the above transactions the Executive Directors and PDMRs listedbelow now have the following holdings in the ordinary share capital of theCompany: +-------------------+------------------------------+---------------------------+|Name |Ordinary Shares in the Company|Percentage of Share capital|| | | |+-------------------+------------------------------+---------------------------+|Majda Labadi |305,740 |0.1804% |+-------------------+------------------------------+---------------------------+|Taghreed Al Shunnar|29,640 |0.0175% |+-------------------+------------------------------+---------------------------+ The issued share capital of Hikma Pharmaceuticals PLC is now 169,435,407 ordinary shares of 10 pence each. Date of Notification: 19 September 2007 Henry KnowlesCompany Secretary020 7399 2760 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Apr 20227:15 amRNSTrading Statement
28th Apr 20226:05 pmRNSTransaction in Own Shares
27th Apr 20226:17 pmRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTransaction in Own Shares
25th Apr 20226:04 pmRNSTransaction in Own Shares
25th Apr 20223:42 pmRNSResult of AGM
25th Apr 20227:00 amRNSNotice of GM
22nd Apr 20226:15 pmRNSTransaction in Own Shares
21st Apr 20226:06 pmRNSTransaction in Own Shares
21st Apr 20222:15 pmRNSAcquisition
20th Apr 20225:59 pmRNSTransaction in Own Shares
20th Apr 20227:00 amRNSFTC preliminary approval for Custopharm
19th Apr 20225:49 pmRNSTransaction in Own Shares
14th Apr 20225:35 pmRNSTransaction in Own Shares
13th Apr 20225:19 pmRNSTransaction in Own Shares
12th Apr 20225:55 pmRNSTransaction in Own Shares
12th Apr 20225:49 pmRNSDirector/PDMR Shareholding
11th Apr 20226:09 pmRNSTransaction in Own Shares
11th Apr 20227:00 amRNSShare Buyback Programme
8th Apr 20225:16 pmRNSTransaction in Own Shares
7th Apr 20225:53 pmRNSTransaction in Own Shares
5th Apr 20225:59 pmRNSTransaction in Own Shares
4th Apr 20226:09 pmRNSTransaction in Own Shares
1st Apr 20226:13 pmRNSTransaction in Own Shares
1st Apr 20225:46 pmRNSBlock listing Interim Review
31st Mar 20226:09 pmRNSTransaction in Own Shares
30th Mar 20225:57 pmRNSTransaction in Own Shares
30th Mar 202212:54 pmRNSTransaction in Own Shares
28th Mar 20226:09 pmRNSTransaction in Own Shares
25th Mar 20225:55 pmRNSTransaction in Own Shares
24th Mar 20226:03 pmRNSTransaction in Own Shares
23rd Mar 20225:08 pmRNSTransaction in Own Shares
22nd Mar 20226:03 pmRNSTransaction in Own Shares
21st Mar 20225:58 pmRNSTransaction in Own Shares
18th Mar 20226:32 pmRNSTransaction in Own Shares
17th Mar 20226:03 pmRNSTransaction in Own Shares
17th Mar 202210:00 amRNSAnnual Financial Report
16th Mar 20225:48 pmRNSTransaction in Own Shares
15th Mar 20225:51 pmRNSTransaction in Own Shares
15th Mar 202210:58 amRNSDirector/PDMR Shareholding
14th Mar 20226:23 pmRNSTransaction in Own Shares
11th Mar 20226:11 pmRNSTransaction in Own Shares
10th Mar 20225:48 pmRNSTransaction in Own Shares
9th Mar 20225:53 pmRNSTransaction in Own Shares
8th Mar 20225:21 pmRNSTransaction in Own Shares
8th Mar 202210:21 amRNSHolding(s) in Company
7th Mar 20225:12 pmRNSTransaction in Own Shares
7th Mar 20221:36 pmRNSDirector/PDMR Shareholding
4th Mar 20226:20 pmRNSTransaction in Own Shares
3rd Mar 20225:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.